The pharmaceutical business is a critical component of the healthcare sector, responsible for drug research, development, manufacture, and distribution. It serves an important role in promoting and preserving public health by studying and developing drugs to prevent, treat, or cure numerous medical disorders.
Three pharma stocks with export contribution of up to 89 percent of Total revenue.
Sun Pharmaceuticals Industries Ltd
Sun Pharmaceutical Industries Ltd manufactures, develops, and markets a diverse variety of branded and generic formulations, as well as Active Pharma Ingredients.
With a market capitalization of Rs 3.34 lakh crore, the shares were trading at Rs 1,392.70 per share, increased around 5.04 percent as compared to the previous closing price of Rs 1,325.85 apiece.
The company’s 68 percent revenue comes from out of india which stands at Rs 29,447.9 crore and the company’s 32 percent of its revenue comes from India which stands at Rs 13,603.1 crore.
Dr Reddys Laboratories Ltd
Dr. Reddy’s Laboratories Ltd is a significant Indian pharmaceutical firm that provides a spectrum of goods and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, and differentiated formulations.
With a market capitalization of Rs 95,301.25 crore, the shares were trading at Rs 5,713.45 per share, increased around 1.43 percent as compared to the previous closing price of Rs 5,632.90 apiece
The company’s 80 percent revenue comes from out of India which stands at Rs 19,699.7 crore and the company’s 20 percent of its revenue comes from India which stands at Rs 4,893.2 crore.
Aurobindo Pharma Ltd
Aurobindo Pharma specializes in the manufacture and commercialization of active pharmaceutical ingredients, generic medications, and related services.
With a market capitalization of Rs 67,201.30 crore, the shares were trading at Rs 1146.90 per share, increased around 0.20 percent as compared to the previous closing price of Rs 1,144.60 apiece.
The company’s 92 percent revenue comes from out of India which stands at Rs 22,882 crore and the company’s 8 percent of its revenue comes from India which stands at Rs 1,973 crore.
Written:- Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
